From ShareVault: Download the White Paper: How Crowdfunding Can Help Life Sciences Companies

Crowdfunding as an Alternative Financing Vehicle

The past five years have been one of the more challenging periods for raising capital in the biotechnology industry, especially for early-stage companies. Numerous factors, including a challenging FDA environment upon NDA submission, long timelines to approval and the high rate of drug failure, have contributed to a dim venture capitalist view of the sector’s prospects. As a result, emerging growth biotechnology companies are increasingly pursuing alternative financing vehicles, including Equity Crowdfunding, to advance their drug development programs.

On April 5th, 2012, the “JOBS Act” (Jumpstart Our Business Startups Act) was signed into law including a provision for Equity Crowdfunding. It allows companies to raise capital in small amounts from large groups of people using the Internet and social media.

In this white paper, author Scott Jordan explains Crowdfunding, the JOBS Act and the influence it may have on your business. Download the paper to learn more about the different platforms available to Life Science companies including Equity and Non-Equity/“Compassionate Use” Crowdfunding. Also covered is an assessment of the value of Equity Crowdfunding for Life Science companies including Seed, Bridge and Side Car financings.

Download the white paper: http://bit.ly/wp-crowdfunding

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: